THROMBOCYTOPENIA IS A THROMBOTIC RISK FACTOR IN PATIENTS WITH POSITIVE ANTIPHOSPHOLIPID ANTIBODIES WITHOUT CLINICAL CRITERIA OF THE DISEASE?

被引：0
|
作者：
Demetrio Pablo, R. [1 ]
Munoz, P. [2 ]
Calvo-Rio, V. [3 ]
Riancho-Zarrabeitia, L. [3 ]
Lopez-Hoyos, M. [4 ]
Martinez-Taboada, V. M. [3 ]
机构：
[1] Hosp Univ Marques de Valdecilla, IDIVAL, Fac Med, UC,Ophtalmol, Santander, Spain
[2] Hosp Univ Marques de Valdecilla, IDIVAL, Fac Med, UC,Primary Care Management, Santander, Spain
[3] Hosp Univ Marques de Valdecilla, IDIVAL, Fac Med, UC,Rheumatol, Santander, Spain
[4] Hosp Univ Marques de Valdecilla, IDIVAL, Fac Med, UC,Immunol, Santander, Spain
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2016年 / 75卷
关键词：
D O I：
10.1136/annrheumdis-2016-eular.5274
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SAT0308
引用
收藏
页码：779 / 779
页数：1
相关论文
共 50 条
  • [21] Clinical Thrombotic Manifestations in SLE Patients With and Without Antiphospholipid Antibodies: A 5-year Follow-up
    Tunde Tarr
    Gabriella Lakos
    Harjit Pal Bhattoa
    Pal Soltesz
    Yehuda Shoenfeld
    Gyula Szegedi
    Emese Kiss
    Clinical Reviews in Allergy & Immunology, 2007, 32 : 131 - 137
  • [22] CLINICAL THROMBOTIC MANIFESTATIONS IN SLE PATIENTS WITH AND WITHOUT ANTIPHOSPHOLIPID ANTIBODIES: A TEN-YEAR FOLLOW-UP
    Tarr, T.
    Nagy, N.
    Cserep, E.
    Zeher, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 1082 - 1082
  • [23] Clinical course of primary immune thrombocytopenia with positive antiphospholipid antibodies: Author's reply
    Ladeira Cruz, Ana Clara
    Colella, Marina Pereira
    De Paula, Erich Vinicius
    Annichinno-Bizzachi, Joyce
    Orsi, Fernanda Andrade
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2020, 74 : 108 - 109
  • [24] Antiphospholipid syndrome without antiphospholipid antibodies at the time of the thrombotic event: Transient 'seronegative' antiphospholipid syndrome?
    Miret, C
    Cervera, R
    Reverter, JC
    GarciaCarrasco, M
    Ramos, M
    Molla, M
    Font, J
    Ingelmo, M
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 1997, 15 (05) : 541 - 544
  • [25] Presence of Antiphospholipid Antibodies as a Risk Factor for Thrombotic Events in Patients with Connective Tissue Diseases and Idiopathic Thrombocytopenic Purpura
    Habe, Koji
    Wada, Hideo
    Matsumoto, Takeshi
    Ohishi, Kohshi
    Ikejiri, Makoto
    Matsubara, Kimiko
    Morioka, Tatsuhiko
    Kamimoto, Yuki
    Ikeda, Tomoaki
    Katayama, Naoyuki
    Mizutani, Hitoshi
    INTERNAL MEDICINE, 2016, 55 (06) : 589 - 595
  • [26] Thrombotic risk of reduced ADAMTS13 activity in patients with antiphospholipid antibodies
    Kim, H. K.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 278 - 278
  • [27] BETA-2-GLYCOPROTEIN-1 AND THROMBOTIC RISK IN PATIENTS WITH ANTIPHOSPHOLIPID ANTIBODIES
    ANKRI, A
    MAHOUN, H
    COUTY, MC
    REBOUL, J
    LESTY, C
    CAMBUSSE, JP
    THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 598 - 598
  • [28] Thrombotic risk of reduced ADAMTS13 activity in patients with antiphospholipid antibodies
    Lee, Seung Jun
    Kim, Ji-Eun
    Han, Kyou-Sup
    Kim, Hyun Kyung
    BLOOD COAGULATION & FIBRINOLYSIS, 2016, 27 (08) : 907 - 912
  • [29] Thrombotic risk stratification by platelet count in patients with antiphospholipid antibodies: a longitudinal study
    Hisada, R.
    Kato, M.
    Sugawara, E.
    Fujieda, Y.
    Oku, K.
    Bohgaki, T.
    Amengual, O.
    Yasuda, S.
    Atsumi, T.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2017, 15 (09) : 1782 - 1787
  • [30] Thrombotic Risk Factors, Antithrombotic Therapy, and Outcomes of Asymptomatic Carriers of Antiphospholipid Antibodies and Patients with Antiphospholipid Syndrome
    Abu-Zeinah, Ghaith
    Oromendia, Clara
    De Sancho, Maria Teresa
    BLOOD, 2017, 130
12345